ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 406 filers reported holding ENCOMPASS HEALTH CORP in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $391,207 | -8.1% | 5,825 | -7.3% | 0.00% | -50.0% |
| Q2 2023 | $425,597 | -47.5% | 6,286 | -58.1% | 0.00% | 0.0% |
| Q1 2023 | $811,013 | -10.6% | 14,991 | -1.2% | 0.00% | 0.0% |
| Q4 2022 | $907,378 | +27.1% | 15,171 | -3.9% | 0.00% | 0.0% |
| Q3 2022 | $714,000 | -19.6% | 15,784 | -0.3% | 0.00% | 0.0% |
| Q2 2022 | $888,000 | -25.3% | 15,836 | -5.3% | 0.00% | -33.3% |
| Q1 2022 | $1,189,000 | +6.5% | 16,724 | -2.2% | 0.00% | +50.0% |
| Q4 2021 | $1,116,000 | +294.3% | 17,096 | +394.1% | 0.00% | +100.0% |
| Q1 2021 | $283,000 | -6.3% | 3,460 | -5.2% | 0.00% | 0.0% |
| Q4 2020 | $302,000 | +15.3% | 3,649 | -9.6% | 0.00% | 0.0% |
| Q3 2020 | $262,000 | -6.4% | 4,035 | +12.5% | 0.00% | 0.0% |
| Q3 2018 | $280,000 | +7.3% | 3,587 | -6.9% | 0.00% | 0.0% |
| Q2 2018 | $261,000 | – | 3,852 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |